Topiramate, an old drug for a new goal, weight reduction in obese patients, cardiometabolic implications

Topiramate

Sabán-Ruiz, J. Alonso-Pacho, A. Fabregate-Fuente, M. De la Puerta González-Quevedo, C. Fabregate-Fuente, R. Tello-Blasco, S. Guerri, A. Topiramate.
Anti Obesity Drug Discovery and Development, suppl: (in press)

Oxidase Inhibitor Febuxostat as a Novel Agent Postulates to Act Against Vascular Inflammation

Oxidase Inhibitor Febuxostat as a Novel Agent Postulates to Act Against Vascular Inflammation

Sabán-Ruiz, J. Alonso-Pacho, A. Fabregate-Fuente, M. and De la Puerta González-Quevedo, C. Xantine
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2013, 12, 94-99

Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy.

Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy.

Sánchez Sánchez O, Sabán Ruiz J.
Med Clin (Barc). 2008 Feb 16;130(5):188-96. Review. Spanish

Abstract enlace